Analysts who follow Kiniksa Pharmaceuticals Ltd (KNSA) on average expect it to climb 125.08% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy.
That average rating earns KNSA an Analyst Ranking of 79, which means it ranks higher than 79 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.
InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.
What's Happening With Kiniksa Pharmaceuticals Ltd Stock Today?
Kiniksa Pharmaceuticals Ltd (KNSA) stock is trading at $15.55 as of 3:19 PM on Monday, Nov 23, an increase of $0.67, or 4.5% from the previous closing price of $14.88. The stock has traded between $15.12 and $15.97 so far today. Volume today is high. So far 684,483 shares have traded compared to average volume of 362,779 shares.
Click Here to get the full report on Kiniksa Pharmaceuticals Ltd (KNSA) Stock.
